Evidence map›Paper›PMID 29796987›Full record

ArticleEndocrine2018

High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma.

Ninni Mu, C Christofer Juhlin, Edneia Tani, Anastasios Sofiadis, Eva Reihnér, Jan Zedenius, Catharina Larsson, Inga-Lena Nilsson

Abstract read
In one paragraph

Article in Endocrine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. [Molecular imaging and biology · 2023
    Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ninni MuDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Ninni.Mu@ki.se.ORCID http://orcid.org/0000-0002-3887-880X
C Christofer JuhlinDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Edneia TaniDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Anastasios SofiadisDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Eva ReihnérDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Jan ZedeniusDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Catharina LarssonDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Inga-Lena NilssonDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePreoperative distinction of follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA) is a diagnostic challenge. Our aim was to investigate whether the Ki-67 proliferation index in fine needle aspiration material can contribute to the diagnosis of FTC.

methodsWe analyzed retrospectively cytological Ki-67 index determined in routine clinical setting and clinical data for 61 patients with FTC, 158 patients with FTA and 15 patients with follicular tumor of uncertain malignant potential (FT-UMP) surgically treated and diagnosed by histopathology at Karolinska University Hospital 2006-2017 (Cohort A). A previously published cohort of 109 patients with follicular tumors was re-analyzed as well (Cohort B).

resultsIn Cohort A, patients with FTC had a higher Ki-67 index (p < 0.001), larger tumor size (p < 0.001) and higher age at diagnosis (p = 0.036) compared to patients with FTA or FT-UMP. Hürthle cell differentiation, present in 50 FTA, 20 FTC and 8 FT-UMP, was associated with higher Ki-67 index (p = 0.009). Multivariate analysis of Cohort A identified a high Ki-67 index (odds ratio [OR]: 1.215, p < 0.001) and large tumor size (OR: 1.038, p < 0.001) as independent predictors of FTC. Results remained consistent after exclusion of Hürthle cell tumors and in pooled analysis of Cohort A + B. The area under curve of the Ki-67 index for predicting FTC was 0.722 and a cut-off for Ki-67 index at above 5% resulted in a specificity at 93% and sensitivity at 31%. Subgroup analysis of FTCs in Cohort A showed an association of higher Ki-67 index to extrathyroidal extension (p = 0.001) as well as widely invasive subtype (p = 0.019) based on the WHO 2017 classification.

conclusionsPre-operative Ki-67 index may add diagnostic information for a subset of patients with follicular thyroid tumors.

Indexed as

Adenocarcinoma, FollicularAdolescentAdultAgedAged, 80 and overBiomarkers, TumorBiopsy, Fine-NeedleCarcinomaCell ProliferationChildCytodiagnosisDisease ProgressionFemaleHumansKi-67 AntigenMaleBiomarkers, TumorKi-67 AntigenCytologyFollicular thyroid tumorsKi-67Proliferation

Identifiers

PMID29796987
PMCPMC6061212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.